# Development of a Breath Test for Monitoring Patients With Liver Disease

> **NCT00244569** · PHASE3 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 120 (estimated)

## Conditions studied

- Fatty Liver
- Cirrhosis

## Interventions

- **DRUG:** 13C-Methacetin
- **DEVICE:** Breath ID Machine

## Key facts

- **NCT ID:** NCT00244569
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244569, "Development of a Breath Test for Monitoring Patients With Liver Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00244569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*